2m 2m 2m 2m 2m 2m 2m
PMV PHARMA (PMVP)
NASDAQ
$1.07-$0.05 (-4.05%)
Price as of Aug 03, 2026 12:23 PM EDT- $59.2MMarket Cap
- -20.71%1-Year Change
- BiotechnologyIndustry
PMV PHARMA (PMVP)
$1.07-$0.05 (-4.05%)
PMVP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.11 | ||
Change | -$0.02 (-1.77%) | ||
Open | $1.13 | ||
High | $1.13 | ||
Low | $1.09 | ||
Previous Close | $1.13 | ||
Volume | 111,551 | ||
30-Day Average Volume | 300,105 | ||
1-Week Change | -10.48% | ||
1-Month Change | -17.16% | ||
1-Year Change | -20.71% | ||
3-Year Change | -83.03% | ||
5-Year Change | -96.74% | ||
Fundamentals | |||
Shares Outstanding | 53.3M | ||
Total Assets | $96.6M | ||
Market Cap | $59.2M | ||
Enterprise Value | $20.7M | ||
Period: QTR TTM FY | |||
Revenue | $980,000.00 | ||
Net Income | -$18.0M | ||
Free Cash Flow | -$19.7M | ||
EBIT | -$18.0M | ||
EBITDA | -$18.0M | ||
Net Working Capital | $87.2M | ||
EPS | -$0.34 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | 21 | ||
P/B | 1 | ||
P/E | -3 | ||
PEG | 12 | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue